Citations

Showing 10 of 108094 citations.

Targeted Neonatal Echocardiography in Patients With Hemodynamic Instability
Bischoff, Adrianne R. , Bhombal, Shazia , Altman, Carolyn A. , Fraga, María V. , Punn, Rajesh , Rohatgi, Ram K., Lopez, Leo , McNamara, Patrick J.

Mayo Clinic

Pediatrics | November 1, 2022 | Volume: 150 | Issue: Supplement 2 | Pages: No page available

10.1542/peds.2022-056415i | PMID 36317979 Get It

Targeted neonatal echocardiography (TNE) has been increasingly used at the bedside in neonatal care to provide an enhanced understanding of physiology, affecting management in hemodynamically unstable patients. Traditional methods of bedside assessment, including blood pressure, heart rate monitoring, and capillary refill are unable to provide a complete picture of tissue perfusion and oxygenation. TNE allows for precision medicine, providing a tool for identifying pathophysiology and to continually reassess rapid changes in hemodynamics. A relationship with cardiology is integral both in training as well as quality assurance. It is imperative that congenital heart disease is ruled out when utilizing TNE for hemodynamic management, as pathophysiology varies substantially in the assessment and management of patients with congenital heart disease. Utilizing TNE for longitudinal hemodynamic assessment requires extensive training. As the field continues to grow, guidelines and protocols for training and indications are essential for ensuring optimal use and providing a platform for quality assurance.
Respiratory Care for Neonates With Congenital Heart Disease
Bronicki, Ronald A., Benitz, W.E. , Yarlagadda, Vamsi V. , Aganga, Devon O. , Kim, Minso , Costello, John M. , Agana, Devon O, Buckley, Jason R. , Porta, Nicolas

Mayo Clinic

Pediatrics | November 1, 2022 | Volume: 150 | Issue: Supplement 2 | Pages: No page available

10.1542/peds.2022-056415h | PMID 36317970 Get It

Preoperative Management of Neonates With Congenital Heart Disease
Ashrafi, Amir H., Mazwi, Mjaye , Sweeney, Nathaly M. , Dorn, Charlotte S. Van , Armsby, Laurie B., Miller, Jacob R. , Ringle, Megan , Justice, Lindsey , Gray, Seth , Van Dorn, Charlotte S, Eghtesady, Pirooz , Levy, Victor Y.

Mayo Clinic

Pediatrics | November 1, 2022 | Volume: 150 | Issue: Supplement 2 | Pages: No page available

10.1542/peds.2022-056415f | PMID 36317975 Get It

Clinicians caring for neonates with congenital heart disease encounter challenges in clinical care as these infants await surgery or are evaluated for further potential interventions. The newborn with heart disease can present with significant pathophysiologic heterogeneity and therefore requires a personalized therapeutic management plan. However, this complex field of neonatal–cardiac hemodynamics can be simplified. We explore some of these clinical quandaries and include specific sections reviewing the anatomic challenges in these patients. We propose this to serve as a primer focusing on the hemodynamics and therapeutic strategies for the preoperative neonate with systolic dysfunction, diastolic dysfunction, excessive pulmonary blood flow, obstructed pulmonary blood flow, obstructed systemic blood flow, transposition physiology, and single ventricle physiology.
Neonatal Congenital Heart Disease Surgical Readiness and Timing
Kwiatkowski, David M. , Ball, Molly K. , Savorgnan, Fabio , Allan, Catherine K. , Roth, Mark D., Roth, Rachel Z., Sexson, Kristen, Tweddell, James S., Williams, Patricia K., Zender, Jill, Levy, Victor Y. , Dearani, Joseph A.

Mayo Clinic

Pediatrics | November 1, 2022 | Volume: 150 | Issue: Supplement 2 | Pages: No page available

10.1542/peds.2022-056415d | PMID 36317977 Get It

Introduction to the Neonatal Cardiac Care Collaborative Supplement
Levy, Victor Y. , Bhombal, Shazia , Villafañe, Juan , McBride, Mary E. , Figueroa, Mayte , Hopper, Andrew , Johnson, Jonathan N. , Costello, John M. , Thiagarajan, Ravi R.

Mayo Clinic

Pediatrics | November 1, 2022 | Volume: 150 | Issue: Supplement 2 | Pages: No page available

10.1542/peds.2022-056415b | PMID 36317968 Get It

Rapid parallel generation of a fluorescently barcoded drop library from a microtiter plate using the plate-interfacing parallel encapsulation (PIPE) chip
Zath, Geoffrey K. , Hoffman, Carter W. , Bikos, Dimitri A. , Abbasi, Reha , Abate, Adam R. , Weitz, David A. , Chang, Connie B. , Hoffman, Carter W , Bikos, Dimitri A , Abbasi, Reha , Abate, Adam R , Weitz, David A , Chang, Connie B , Sperling, Ralph A.

Mayo Clinic

Lab on a Chip | November 1, 2022 | Volume: 22 | Issue: 23 | Pages: 4735-4745

10.1039/d2lc00909a | PMID 36367139 Get It

The Plate-Interfacing Parallel Encapsulation (PIPE) microfluidic chip generates drops of up to 96 different conditions in parallel, such as barcoded drop libraries, by interfacing individual drop makers with a standard 384-well microtiter plate.
Letter to the Editor: The Effectiveness of Empathic Communication Training on Goals of Care and End-of-Life Conversations
Lagunas, Meg , Petit, Samuel D., Deming, James, Horecki, Patty, Brustad, Rebecca, Manz, James, Okuno, Scott H. , Christensen, Susan M., Manz, James W., Petit, Sam D., Deming, James R.

Mayo Clinic

Journal of Palliative Medicine | November 1, 2022 | Volume: 25 | Issue: 11 | Pages: 1616-1617

10.1089/jpm.2022.0291 | PMID 36608318 Get It

Epilepsy center characteristics and geographic region influence presurgical testing in the United States
Ahrens, Stephanie M. , Arredondo, Kristen H. , Bagić, Anto , Bai, Shasha , Chapman, Kevin , Ciliberto, Michael A. , Clarke, Dave , Fountain, Nathan B. , Gavvala, Jay R. , Perry, Μ. Scott , Herman, Susan T. , Ostendorf, Adam P. , Bagić, Anto I , Fountain, Nathan , Gavvala, Jay R , Perry, Michael Scott , Rossi, Kyle C , Wong-Kisiel, Lily C. , Ostendorf, Adam P , Arredondo, Kristen H , Eisner, Mariah , Wong‐Kisiel, Lily C.

Mayo Clinic

Epilepsia | November 1, 2022 | Volume: 64 | Issue: 1 | Pages: 127-138

10.1111/epi.17452 | PMID 36317952 Get It

Abstract Objective Persons with drug‐resistant epilepsy may benefit from epilepsy surgery and should undergo presurgical testing to determine potential candidacy and appropriate intervention. Institutional expertise can influence use and availability of evaluations and epilepsy surgery candidacy. This census survey study aims to examine the influence of geographic region and other center characteristics on presurgical testing for medically intractable epilepsy. Methods We analyzed annual report and supplemental survey data reported in 2020 from 206 adult epilepsy center directors and 136 pediatric epilepsy center directors in the United States. Test utilization data were compiled with annual center volumes, available resources, and US Census regional data. We used Wilcoxon rank‐sum, Kruskal–Wallis, and chi‐squared tests for univariate analysis of procedure utilization. Multivariable modeling was also performed to assign odds ratios (ORs) of significant variables. Results The response rate was 100% with individual element missingness < 11% across 342 observations undergoing univariate analysis. A total of 278 complete observations were included in the multivariable models, and significant regional differences were present. For instance, compared to centers in the South, those in the Midwest used neuropsychological testing (OR = 2.87, 95% confidence interval [CI] = 1.2–6.86; p = .018) and fluorodeoxyglucose–positron emission tomography (OR = 2.74, 95% CI = = 1.14–6.61; p = .025) more commonly. For centers in the Northeast (OR = .46, 95% CI = .23–.93; p = .031) and West (OR = .41, 95% CI = .19–.87; p = .022), odds of performing single‐photon emission computerized tomography were lower by nearly 50% compared to those in the South. Center accreditation level, demographics, volume, and resources were also associated with varying individual testing rates. Significance Presurgical testing for drug‐resistant epilepsy is influenced by US geographic region and other center characteristics. These findings have potential implications for comparing outcomes between US epilepsy centers and may inject disparities in access to surgical treatment.
Care of the Fetus With Congenital Cardiovascular Disease: From Diagnosis to Delivery
Haxel, Caitlin , Johnson, Jonathan N. , Hintz, Susan R. , Renno, Markus S. , Zyblewski, Sinai C. , Glickstein, Julie S. , Ruano, Rodrigo , Donofrio, Mary T.

Mayo Clinic

Pediatrics | November 1, 2022 | Volume: 150 | Issue: Supplement 2 | Pages: No page available

10.1542/peds.2022-056415c | PMID 36317976 Get It

The majority of congenital cardiovascular disease including structural cardiac defects, abnormalities in cardiac function, and rhythm disturbances can be identified prenatally using screening obstetrical ultrasound with referral for fetal echocardiogram when indicated. Diagnosis of congenital heart disease in the fetus should prompt assessment for extracardiac abnormalities and associated genetic abnormalities once parental consent is obtained. Pediatric cardiologists, in conjunction with maternal-fetal medicine, neonatology, and cardiothoracic surgery subspecialists, should counsel families about the details of the congenital heart defect as well as prenatal and postnatal management. Prenatal diagnosis often leads to increased maternal depression and anxiety; however, it decreases morbidity and mortality for many congenital heart defects by allowing clinicians the opportunity to optimize prenatal care and plan delivery based on the specific lesion. Changes in prenatal care can include more frequent assessments through the remainder of the pregnancy, maternal medication administration, or, in selected cases, in utero cardiac catheter intervention or surgical procedures to optimize postnatal outcomes. Delivery planning may include changing the location, timing or mode of delivery to ensure that the neonate is delivered in the most appropriate hospital setting with the required level of hospital staff for immediate postnatal stabilization. Based on the specific congenital heart defect, prenatal echocardiogram assessment in late gestation can often aid in predicting the severity of postnatal instability and guide the medical or interventional level of care needed for immediate postnatal intervention to optimize the transition to postnatal circulation.
Evaluation and Management of Noncardiac Comorbidities in Children With Congenital Heart Disease
Chowdhury, Devyani , Toms, Rune, Bindom, Sharell M., Ather, Mishaal, Jaquiss, Robert D.B. , Johnson, Jonathan N. , Brumbaugh, Jane E.

Mayo Clinic

Pediatrics | November 1, 2022 | Volume: 150 | Issue: Supplement 2 | Pages: No page available

10.1542/peds.2022-056415e | PMID 36317973 Get It

Outcomes for patients with neonatal heart disease are affected by numerous noncardiac and genetic factors. These can include neonatal concerns, such as prematurity and low birth weight, and congenital anomalies, such as airway, pulmonary, gastrointestinal, and genitourinary anomalies, and genetic syndromes. This section will serve as a summary of these issues and how they may affect the evaluation and management of a neonate with heart disease. These noncardiac factors are heavily influenced by conditions common to neonatologists, making a strong argument for multidisciplinary care with neonatologists, cardiologists, surgeons, anesthesiologists, and cardiovascular intensivists. Through this section and this project, we aim to facilitate a comprehensive approach to the care of neonates with congenital heart disease.